Fenway-Lateral Flow Assay Evaluations
Closed Solicitation Posted
- Solicitation number
- 000HCKBG-2024-86298
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Atlanta, Georgia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) intends to issue a sole source order to the Fenway Institute for the procurement and delivery of lateral flow test results from persons administered integrase inhibitor-based antiretroviral therapy or long-acting pre-exposure prophylaxis (PrEP). The agency is seeking these services under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1), and is requesting information from interested parties to determine if a competitive procurement should be conducted. Interested vendors must submit their capabilities statement and pricing information by July 16, 2024 at 2:00 PM ET.
This procurement is not set aside for any specific business type. The CDC has determined that the Fenway Institute is the only reasonably available source due to its unique expertise and capabilities, including a clientele of at least 100 persons on injectable cabotegravir long-acting (CAB-LA) PrEP and a high proportion of patients on bictegravir-based treatment. The estimated procurement amount is $200,000, and the place of performance is Atlanta, GA.
Notice text
NOTICE OF INTENT TO ISSUE AN ORDER. This is not a request for competitive proposals/quotes. The Centers for Disease Control and Prevention (CDC) hereby announces its intent to issue a sole source order to Fenway Institute for ntegrase Inhibitor-based Antiretroviral Therapy or Long-acting Pre-Exposure Prophylaxis (PrEP).
The NAICS code for this acquisition is 541715.
A determination by the Government not to compete this proposed action will be based on responses to this notice and is solely in the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
All vendors must be registered in the System for Award Management (SAM) at www.sam.gov , prior to an award of a federal contract.
This action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit quotations.
This is not a request for competitive quotations; however, the Government will review any/all product, capabilities, and pricing information submitted prior to the closure of this notice. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Responsible sources that believe they possess the expertise and capabilities identified above are hereby afforded the opportunity to submit to the Contracting Officer by the due date of this notice, their written capabilities statement and pricing information in the format they choose, not to exceed 10 pages. Please forward, as applicable, any capabilities, product, pricing information (for products, etc.), and/or other pertinent information to Ronnie Williams, Contracting Officer, CDC, OAS, through email at oga3@cdc.gov.
Any responses should be emailed to Ronnie Williams at oga3@cdc.gov by July 16, 2024 at 2:00 PM. ET Local
Files
| File | Type | Posted |
|---|---|---|
| A13_SSJ_CO Signed.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement | CDC Office of Acquisition Services | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity